Allergen immunotherapy in China
- PMID: 38260178
- PMCID: PMC10801290
- DOI: 10.3389/falgy.2023.1324844
Allergen immunotherapy in China
Abstract
Allergen immunotherapy (AIT) is an etiological treatment strategy that involves administering escalating doses of clinically relevant allergens to desensitize the immune system. It has shown encouraging results in reducing allergy symptoms and enhancing patients' quality of life. In this review, we offer a thorough overview of AIT in China, examining its efficacy, safety, current practices, and prospects. We further underscore the progress made in AIT research and clinical applications, as well as the distinct challenges and opportunities that China faces in this area.
Keywords: adjuvant; allergen extracts; allergen immunotherapy; efficacy; safety.
© 2024 Yang, Li and Zhu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Similar articles
-
A Comprehensive Overview of Allergen-specific Immunotherapy Types, Recombinant and Natural Extract Allergens in the Diagnosis and Treatment of Allergies.Iran J Allergy Asthma Immunol. 2022 Oct 26;21(5):494-511. doi: 10.18502/ijaai.v21i5.11038. Iran J Allergy Asthma Immunol. 2022. PMID: 36341559 Review.
-
Management of the polyallergic patient with allergy immunotherapy: a practice-based approach.Allergy Asthma Clin Immunol. 2016 Jan 11;12:2. doi: 10.1186/s13223-015-0109-6. eCollection 2016. Allergy Asthma Clin Immunol. 2016. PMID: 26759555 Free PMC article. Review.
-
Chinese Guideline on allergen immunotherapy for allergic rhinitis.J Thorac Dis. 2017 Nov;9(11):4607-4650. doi: 10.21037/jtd.2017.10.112. J Thorac Dis. 2017. PMID: 29268533 Free PMC article. Review.
-
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.Allergy. 2022 Mar;77(3):907-919. doi: 10.1111/all.15012. Epub 2021 Jul 26. Allergy. 2022. PMID: 34287971
-
House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis.J Thorac Dis. 2019 Aug;11(8):3616-3625. doi: 10.21037/jtd.2019.06.35. J Thorac Dis. 2019. PMID: 31559069 Free PMC article. Review.
Cited by
-
Comparative safety analysis of coseasonal versus preseasonal Artemisia annua sublingual immunotherapy for allergic rhinitis.Eur Arch Otorhinolaryngol. 2025 Apr;282(4):1941-1950. doi: 10.1007/s00405-025-09262-7. Epub 2025 Feb 22. Eur Arch Otorhinolaryngol. 2025. PMID: 39987413 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources